Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    xbiotech
Show Display Options
Rank Status Study
1 Active, not recruiting A Pharmacokinetic Study of MABp1 in Healthy Volunteers
Condition: Healthy
Intervention: Biological: MABp1
2 Active, not recruiting A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer
Conditions: Symptomatic Colorectal Cancer;   Advanced Colorectal Cancer;   Colorectal Cancer With Cachexia
Interventions: Biological: Xilonix;   Biological: Placebo
3 Completed A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
Condition: Pyoderma Gangrenosum
Intervention: Biological: Xilonix
4 Completed A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus
Condition: Staphylococcus Aureus Bacteremia
Interventions: Biological: 514G3;   Drug: Placebo;   Drug: Standard IV antibiotic therapy
5 Completed Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris
Condition: Acne Vulgaris
Intervention: Drug: RA-18C3
6 Active, not recruiting A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Xilonix;   Drug: Placebo
7 Completed A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: T2-18C3 therapeutic antibody
8 Completed Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis
Condition: Psoriasis
Intervention: Drug: RA-18C3
9 Completed Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
Condition: Patients Undergoing Repeat Peripheral Artery Revascularization
Interventions: Drug: CV-18C3;   Procedure: Standard of Care
10 Completed Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
Condition: Hematologic Malignancies
Intervention: Drug: CA-18C3
11 Completed A First in Man Study of MABp1 in Patients With Advanced Cancers
Condition: Advanced Cancers
Intervention: Drug: MABp1

Study has passed its completion date and status has not been verified in more than two years.